Cogent Biosciences
COGT
Cogent Biosciences (COGT) news
Recent news
Cogent Biosciences reports FDA acceptance of NDA
AInvest Wire · Sep 15, 2026Cogent Biosciences: FDA states no advisory committee planned and no review issues identified
AInvest Wire · Sep 15, 2026Cogent Biosciences: FDA accepts NDA for bezuclastinib in advsm with PDUFA date June 29, 2027
AInvest Wire · Sep 15, 2026Cogent Biosciences announces FDA acceptance of new drug application (NDA) for bezuclastinib in patients with advanced systemic mastocytosis (ADVSM)
AInvest Wire · Sep 15, 2026Cogent Biosciences - To purchase minimum percentages of bezuclastinib products from Hovione - SEC filing
AInvest Wire · Sep 2, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.